Page last updated: 2024-08-24

rhodamine 123 and tandutinib

rhodamine 123 has been researched along with tandutinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambudkar, SV; Chen, JJ; Chen, ZS; Dai, CL; Deng, W; Fu, LW; Liang, YJ; Ohnuma, S; Zeng, MS; Zhao, XQ	1

Other Studies

1 other study(ies) available for rhodamine 123 and tandutinib

Article	Year
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Jun-14, Volume: 49, Issue:3 Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Mice; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; NIH 3T3 Cells; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Rhodamine 123	2013

Article

Year

Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Jun-14, Volume: 49, Issue:3

Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Mice; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; NIH 3T3 Cells; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Rhodamine 123

2013